Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss company earnings and the future of genome sequencing.

Whole genome sequencing can be an exceptionally valuable tool in cancer diagnostics. The application of this technique can ...

The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...

Roche introduces Sequencing by Expansion (SBX) technology in a webinar just a few days before the AGBT meeting takes place in ...

A Texas-based lab is used by law enforcement in cases where local and state labs have failed to extract DNA from degraded or ...

The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, ...

Edward Haynes reveals how advanced sequencing technologies are assisting food companies in their mission to deliver quality ...

Evo-2, a groundbreaking AI model, generates DNA sequences and aids in genome analysis, enhancing genetic research.

After five years of painstaking lab work, more than 350,000 hours of genome sequencing and £200 million ($253 million) in investment, UK Biobank has completed and released the full sequencing ...